Patient-centred treatments for type 2 diabetes.
Kudva
Yogish C
YC
Division of Endocrinology and Metabolism, Mayo Clinic, Rochester, MN 55905, USA. kudva.yogish@mayo.edu
Montori
Victor M
VM
D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy*; D006801:Humans; D007004:Hypoglycemic Agents / Q000008:administration & dosage*; D007328:Insulin / Q000008:administration & dosage / Q000031:analogs & derivatives*; D000069036:Insulin Glargine; D061268:Insulin Lispro; D049528:Insulin, Long-Acting; D018802:Patient-Centered Care; D016032:Randomized Controlled Trials as Topic
D007004:Hypoglycemic Agents; D007328:Insulin; D061268:Insulin Lispro; D049528:Insulin, Long-Acting; D000069036:Insulin Glargine